[Consultant32452]

It's regulation that is stopping me from buying the cheapest price. I don't want the US to force a particular price in the US. And even if they did, I would still want to be able to buy from anywhere in the world, regardless of where the lowest price is.

[hn_throwaway_99]

Yeah, you want to take advantage of the regulation of those other countries, which you can't get in the US.

[x86_64Ubuntu]

I'm not sure why people don't see the problem with "I don't want any price regulation in the US, but I want to personally benefit from price regulation done in other countries". It's a whole different level of selfishness.

[Consultant32452]

Can you describe how selfishness comes into play? I want everyone to be able to purchase at the lowest price and don't want them to be limited to buying only from the US.

[x86_64Ubuntu]

Because they are voting for no regulation and no M4A in their own country, while eating off the plate of countries that do negotiate drug prices and have socialized healthcare.

[Consultant32452]

Which countries are you referring to that negotiate drug prices? Up thread we were discussing the opposite: price controls.

[ars]

And other countries benefit from the high drug prices in America that fund pharmaceutical research.

I don't see them gnashing their teeth over the ethical considerations of that.

[x86_64Ubuntu]

Pharma spends more money on marketing than they do on R&D, the whole excuse that the costs are largely driven by research is tired and debunked.

[dantheman]

You mean the regulations that limit competition in the US and restrict manufactures and grant monopoly rights? These are the regulations that are good right?

[hn_throwaway_99]

What are you talking about when it comes to manufacturing insulin? I mean, yes, I definitely do want regulations around the safety of drug manufacturing, but beyond that what regulations specifically are you referring to that restrict the manufacturing of insulin?

[Consultant32452]

One example:

>The second reason, the authors noted, is that there isn't significant competition in the U.S. insulin market. Price competition typically comes from the introduction of a generic drug that directly competes with a branded product.

>But the authors said that current insulin makers have blocked the entry to such products by getting new patents based on things such as a new delivery device.

https://www.usnews.com/news/health-news/articles/2019-11-07/...

Patent reform would help bring generics on the market and reduce prices.

[Consultant32452]

Let's not forget the need for patent reform in this area. The current state of patents around drugs in the US is crazy.